ICP
IRWD icon

Interchange Capital Partners’s Ironwood Pharmaceuticals IRWD Stock Holding History

Interchange Capital Partners’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-193
Closed -$2K – 656
2020
Q4 		$2K Buy
+193
New +$2.11K ﹤0.01% 1089

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Interchange Capital Partners's IRWD Position: Q1 2021 in Review

Interchange Capital Partners sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2021, closing a stake of 193 shares — an estimated $2K sold.

Interchange Capital Partners first reported a position in IRWD in Q4 2020 and held it in 1 quarter. The position peaked at $2K in Q4 2020. 209 funds tracked by Wall St. Rank hold IRWD as of Q1 2021.

  • Interchange Capital Partners reported no remaining Ironwood Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Interchange Capital Partners sold 193 Ironwood Pharmaceuticals shares in Q1 2021, an estimated $2K.
  • Interchange Capital Partners first reported a position in Ironwood Pharmaceuticals in Q4 2020 and held it in 1 quarter.
  • Interchange Capital Partners's Ironwood Pharmaceuticals position peaked at $2K in Q4 2020.
  • 209 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2021.

Based on Interchange Capital Partners's 13F filing for Q1 2021, filed 5 May 2021.